AMYOTROPHIC LATERAL SCLEROSIS Experts

• Research area/topic:
  Identification of defects in oligodendrocytes (OL) in familial and sporadic ALS and creation of an all human OL-neuron coculture system for screens of novel drugs that correct OL defects
• Department of Development and Regeneration, University Hospitals Leuven - Gasthuisberg
  
• catherine.**********@***euven.be

Claim this profile

• Research area/topic:
  Translational research on the role of ephrin system in the pathogenesis of amyotrophic lateral sclerosis
• Department of Neurology, University Hospitals Leuven - Gasthuisberg
  
• philip.********@***euven.be

Claim this profile

• Research area/topic:
  Preclinical testing of histone deacetylase 6 (HDAC6) inhibitors in a FUS mouse model of amyotrophic lateral sclerosis (ALS)
• Research Group Experimental Neurology (Neurology Department), University Hospitals Leuven - Gasthuisberg
  
• Ludo.Van********@***euven.vib.be

Claim this profile

• Research area/topic:
  MRI biomarkers in ALS
• University of Alberta
  

Claim this profile

• Research area/topic:
  Promoting protection of functionally intact motor units in amyotrophic lateral sclerosis (ALS).
• University of Alberta
  
• kelvin******@***berta.ca

Claim this profile

• Research area/topic:
  RNA-ALS: Dysregulation of RNA in the pathogenesis of ALS
• McGill Department of Neurology, Montreal Neurological Institute and Hospital
  
• heather*******@***ill.ca

Claim this profile

• Research area/topic:
  Synaptic targets for therapeutic protection of motor function in a genetic model of ALS
• Centre Hospitalier de l'Université de Montréal
  

Claim this profile

• Research area/topic:
  Regulation of motor neuron identity and circuit development
• Montreal Neurological Institute and Hospital
  

Claim this profile

• Research area/topic:
  Loss of VAPB Function in Amyotrophic Lateral Sclerosis-8 (ALS8)
• Ottawa Hospital Research Institute
  
• jng***@***tawa.ca

Claim this profile

• Research area/topic:
  Canadian ALS Research Network (CALS)
• Sunnybrook Health Sciences Centre
  
• jane.m*******@***nybrook.ca

Claim this profile

• Research area/topic:
  The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis
• University of Toronto
  

Claim this profile

• Research area/topic:
  Computation and theory to predict structures and mechanisms for protein misfolding in amyotrophic lateral sclerosis
• University of British Columbia
  

Claim this profile

• Research area/topic:
  Folding and aggregation of ALS-associated mutant superoxide dismutases
• University of Waterloo
  
• meie****@***terloo.ca

Claim this profile

• Research area/topic:
  CDNF and MANF in genetic models of ALS
• Biocenter 1, University of Helsinki
  
• merja.h.v**********@***sinki.fi

Claim this profile

• Research area/topic:
  Study of the Expression of Micro-RNA as Biomarker Diagnosis and Prognosis in Amyotrophic Lateral Sclerosis- FR
• CHU - Hôpitaux de Bordeaux
  
• anne_cecil**********@***_bordeaux.fr

Claim this profile

• Research area/topic:
  Bumetanide treatment of the early alteration of chloride homeostasis in ALS mouse spinal motoneurons
• Institut de Neurosciences cognitives et intégratives d'Aquitaine INCIA
  
• pascal.br*********@***ordeaux.fr

Claim this profile

• Research area/topic:
  Study of Mitochondrial Functions and Oxidative Stress in ALS Patients
• CHU de Clermont-Ferrand - Hôpital d'Estaing
  
• cbout*****@***_clermontferrand.fr

Claim this profile

• Research area/topic:
  DEMENTIA : Exploiting genetic biomarkers of neurodegenerative diseases for developing early diagnostic tests and possible treatments - FR
• Faculté des Sciences de Santé
  
• David.M*******@***ourgogne.fr

Claim this profile

• Research area/topic:
  First study in France searching a link between Amyotrophic Lateral Sclerosis (ALS) and beta-N-methylamino-L-alanine (BMAA) cyanotoxin
• Pôle Psychiatrie, Neurologie et Rééducation Neurologique, CHU de Grenoble site Nord - Hôpital Albert Michallon
  

Claim this profile

• Research area/topic:
  First study in France searching a link between Amyotrophic Lateral Sclerosis (ALS) and beta-N-methylamino-L-alanine (BMAA) cyanotoxin
• Pôle Psychiatrie, Neurologie et Rééducation Neurologique, CHU de Grenoble site Nord - Hôpital Albert Michallon
  
• elag*****@***_grenoble.fr

Claim this profile

• Research area/topic:
  C9ORF72-ALS : Role of C9ORF72 in Amyotrophic Lateral Sclerosis - FR
• IGBMC - CNRS UMR 7104 - Inserm U 1258, Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
  
• ncha****@***mc.fr

Claim this profile

• Research area/topic:
  GIFT-ALS: Growth factor preparations From plaTelets-Amyotrophic Lateral Sclerosis
• Pôle Santé Publique, Pharmacie et Pharmacologie, CHRU de Lille
  
• david******@***u_lille.fr

Claim this profile

• Research area/topic:
  Potential role for nocturnal PtcCO2 monitoring in the close follow up of amyotrophic lateral sclerosis patients
• Pôle Cardiovasculaire et Pulmonaire, CHRU de Lille - Hôpital Albert Calmette
  
• tpe***@***u.lille.fr

Claim this profile

• Research area/topic:
  BMAALS: First study in France seraching a link between Amyotrophic Lateral Sclerosis and BMAA's cyanotoxin
• EA3174, Faculté de médecine de Limoges
  CHU de Limoges - Hôpital Dupuytren
  CHU de Limoges - Hôpital Dupuytren
  
• philippe.*********@***lim.fr

Claim this profile

• Research area/topic:
  Population-based study to compare ALS incidence, mortality rates and phenotype between European and Hispanic populations in relation to genetic ancestral origin
• Faculté des Sciences et Techniques
  

Claim this profile

• Research area/topic:
  FaSMALS : Common Pathogenic Pathways and Therapeutics for SMA and ALS motoneuron diseases - FR
• INSERM UMR 901, Parc scientifique et technologiques de Luminy
  CHU de Montpellier - Hôpital Saint-Eloi
  
• cedric******@***erm.fr

Claim this profile

• Research area/topic:
  MITOTARGET: mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics
• Parc scientifique et technologiques de Luminy
  
• in**@***phos.com

Claim this profile

• Research area/topic:
  MITOTARGET: mitochondrial apoptotic pathways in neurodegenerative diseases and assessment of the effects of new small molecules (WP4)
• UMR6216 - CNRS - université de la Méditerranée, Parc scientifique et technologiques de Luminy
  
• pett****@***m.univ_mrs.fr

Claim this profile

• Research area/topic:
  MITOTARGET: dysfonction mitochondriale dans les maladies neurodégénératives: vers de nouvelles thérapies (coordination)
• Parc scientifique et technologiques de Luminy
  
• jv***@***phos.com

Claim this profile

• Research area/topic:
  FaSMALS : Common Pathogenic Pathways and Therapeutics for SMA and ALS motoneuron diseases - FR
• INSERM UMR 901, Parc scientifique et technologiques de Luminy
  CHU de Montpellier - Hôpital Saint-Eloi
  
• cedric******@***erm.fr

Claim this profile

• Research area/topic:
  ALS in Herault: epidemiology ans exposure into and outside the thau cluster
• Département de Neurologie, CHRU de Montpellier - Hôpital Gui de Chauliac
  Département Neurologie, CHRU de Montpellier - Hôpital Gui de Chauliac
  
• w_c***@***_montpellier.fr

Claim this profile

• Research area/topic:
  From knowledge base of the pathogenic astrocyte-motoneuron communication in amyotrophic lateral sclerosis to therapeutic approaches
• CHU de Montpellier - Hôpital Saint-Eloi
  
• florenc********@***v_montp2.fr

Claim this profile

• Research area/topic:
  Evaluation of new inhibitors of LIMK1 and LIMK2, kinases of the Rho-GTPase pathway, in a mouse model of amyotrophic lateral sclerosis
• UPR4301 Centre de biophysique moléculaire (CBM)
  
• helene.b********@***s_orleans.fr

Claim this profile

• Research area/topic:
  The issue of prenatal / preimplantation diagnosis in parentage information in neurogenetic and neuromuscular dominant diseases
• Centre de génétique moléculaire et chromosomique, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  Service de Génétique clinique et Médicale, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• alexand*******@***p.fr

Claim this profile

• Research area/topic:
  MitoMotor: CHCHD10 mutations: how mitochondrial dysfunction leads to motor neuron disease
• Unité INSERM U 1141 - Neuroprotection du cerveau en développement, CHU Paris - Hôpital Robert Debré
  
• vincent.*********@***erm.fr

Claim this profile

• Research area/topic:
  From Movement Preparation to Gait Execution in ALS: : Combined Neurophysiological and Neuroimaging Approaches - FR
• CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  Département de Neurologie - Pôle des Maladies du Système Nerveux, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  
• pierre_fran***********@***.aphp.fr

Claim this profile

• Research area/topic:
  Presymptomatic neuromuscular junction defects and compensatory mechanisms in ALS
• Département de Neurologie - Pôle des Maladies du Système Nerveux, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  

Claim this profile

• Research area/topic:
  Role of TDP-43 in ALS pathogenesis: understanding TDP-43 aggregates neurotoxicity and the role of tunneling nanotubes in their spreading
• Azienda Ospedaliera Universitaria "Federico II"
  Département de Biologie cellulaire et infection, Institut Pasteur
  
• chiara.*******@***teur.fr

Claim this profile

• Research area/topic:
  New gene therapy for C9ORF72-linked ALS-FTD
• Institut de Myologie - Hôpital Pitié-Salpêtrière
  
• m.ba*****@***titut_myologie.org

Claim this profile

• Research area/topic:
  Peripheral macrophages as a promising target to modulate ALS disease progression
• Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• christian*********@***c.fr

Claim this profile

• Research area/topic:
  Gene hunting in familial Amyotrophic Lateral Sclerosis
• Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• stephanie.**********@***_institute.org

Claim this profile

• Research area/topic:
  Project SOPHIA: Sampling and biomarker OPtimization and Harmonization In ALS and other motor neuron diseases - FR
• Département de Neurologie - Pôle des Maladies du Système Nerveux, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• francois*********@***p.fr

Claim this profile

• Research area/topic:
  Study of the interactions between microglial cells, macrophages and neurons from three axes in an animal model of amyotrophic lateral sclerosis
• Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• severine********@***erm.fr

Claim this profile

• Research area/topic:
  Implication of peripheral macrophages in ALS
• Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• aude.*****@***_institute.org

Claim this profile

• Research area/topic:
  Localisation and identification of causative genes for amyotrohic lateral sclerosis
• Centre de génétique moléculaire et chromosomique, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  Centre de Génétique Moléculaire et Chromosomique, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  
• eric.l******@***p.fr

Claim this profile

• Research area/topic:
  Study of the pathological consequences of the loss of function of the C9ORF72 gene and its implication in autophagy
• Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• hortense.*********@***_institute.org

Claim this profile

• Research area/topic:
  Predict to prevent frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)
• Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  Centre des maladies cognitives et comportementales, CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
  Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
  
• annabell********@***p.fr

Claim this profile

• Research area/topic:
  Can a spinal interneuropathy contribute to motoneuron degeneration in ALS? An electrophysiological study on patients and mouse models of ALS
• Université Paris Descartes - Paris 5
  
• daniel.********@***isdescartes.fr

Claim this profile

• Research area/topic:
  Identification and characterization of gene mutations in patients with azoospermia by maturation
• Histologie embryologie, biologie de la reproduction, cytogénétique et génétique médicale, Centre hospitalier intercommunal Poissy-Saint-Germain-en-Laye
  Service histo-embryologie, cytogénétique, génétique médicale et biologie de la reproduction, Centre hospitalier intercommunal Poissy-Saint-Germain-en-Laye
  
• fvia****@***_poissy_st_germain.fr

Claim this profile

• Research area/topic:
  ToFU: Interactions between TAU, FUS and TDP-43 in neurodegenerative diseases - FR
• Université de Strasbourg, Faculté de médecine de Strasbourg - Louis Pasteur
  
• ldu****@***stra.fr

Claim this profile

• Research area/topic:
  Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
• INSERM U 692, Faculté de médecine de Strasbourg - Louis Pasteur
  
• loef****@***stra.fr

Claim this profile

• Research area/topic:
  SUMOylation and aggregation of TDP43: roles in the pathophysiology of amyotrophic lateral sclerosis
• CHRU de Tours - Hôpital Bretonneau
  
• vou***@***.univ_tours.fr

Claim this profile

• Research area/topic:
  Study of the functions of SMS and TDP-43, whose defectslead to Spinal Muscular Atrophy and Amyotrophic Lateral Sclérosis respectively, in the biogenesis of the small Cajal body-specific and small nucleolar RNPs
• Institut des sciences de l'ingénierie et des systèmes
  
• severine*********@***v_loraine.fr

Claim this profile

• Research area/topic:
  In vitro analysis of the neuromuscular junction in amyotrophic lateral sclerosis. Role of anoctamine 6
• Institut des Neurosciences de Montpellier
  
• frederiq*********@***erm.fr

Claim this profile

• Research area/topic:
  thwart TDP-43-induced mitochondrial defects in amyotrophic lateral sclerosis
• Mécanismes moléculaires dans les démences neurodégénératives (MMDN)
  
• jean_charl**********@***ntpellier.fr

Claim this profile

• Research area/topic:
  New therapeutic strategy in ALS based on metabolic status and associated metabolic disorders
• Université de Tours
  
• helene*******@***v_tours.fr

Claim this profile

• Research area/topic:
  Is spinal motoneuron degeneration in ALS caused by their abnormal excitability?
• Centre de Neurophysique, Physiologie et Pathologie - CNRS UMR 8119
  
• marin.******@***isdescartes.fr

Claim this profile

• Research area/topic:
  MAIV: Investigation of time-dependent axon/muscle contacts and formation of mature neuromuscular end plates between human motor neurons
• Institution: Information not provided - DE
  

Claim this profile

• Research area/topic:
  JPND - Fly-SMALS: Common RNA-dependent pathways for motor neuron degeneration in spinocerebellar muscular atrophy and amyotrophic lateral sclerosis (coordination)
• Universitätsklinikum Aachen
  Klinik für Neurologie, Universitätsklinikum Aachen
  Fakultät für Mathematik, Informatik und Naturwissenschaften, RWTH Aachen
  

Claim this profile

• Research area/topic:
  Role of PGC-1A in the evolution of amyotrophic lateral sclerosis and effects of its regulation
• Universitätsklinikum Bonn
  
• patric*******@***.uni_bonn.de

Claim this profile

• Research area/topic:
  CureALS: Stress granules and proteostasis in motor neurons: towards a mechanistic understanding of ALS (coordination)
• Max Planck Institute of Molecular Cell Biology and Genetics
  
• alb****@***_cbg.de

Claim this profile

• Research area/topic:
  Nutrition and Quality of Life in Amyotrophic Lateral Sclerosis
• Universitätsklinikum Essen
  Universitätsklinikum Essen
  
• tim.hag*******@***essen.de

Claim this profile

• Research area/topic:
  MITOTARGET: mitochondrial membrane properties in the process of neurodegeneration and assessment of the effects of new small molecules (WP2)
• Johann Wolfgang Goethe-Universität Frankfurt
  
• Pharma******@***uni_frankfurt.de

Claim this profile

• Research area/topic:
  ROCK-ALS : Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALS -DE-
• Universitätsmedizin Göttingen
  Universitätsmedizin Göttingen
  
• pli****@***g.de

Claim this profile

• Research area/topic:
  REALS: Repurposed Enoxacin for the treatment of patients with Amyotrophic Lateral Sclerosis -DE-
• Max-Planck-Institut für Molekulare Biomedizin, Max-Planck-Gesellschaft
  
• erik.st********@***_muenster.mpg.de

Claim this profile

• Research area/topic:
  Cell Biology of the FTD/ALS Associated Nuclear Splice Factor TDP-43
• Zentrum für Neurologie, Hertie-Institut für klinische Hirnforschung (HIH)
  
• Philip*******@***_tuebingen.de

Claim this profile

• Research area/topic:
  MITOTARGET: in vivo evidence of mitochondrial-targeted therapeutics (WP5)
• Institut für Medizinische Genetik und angewandte Genomik Tübingen
  Behandlungs- und Forschungszentrum für Seltene Erkrankungen ZSE Tübingen
  
• olaf.*****@***.uni_tuebingen.de

Claim this profile

• Research area/topic:
  Epidemiology of motoneuron diseases - A case-control study
• Universitäts- und Rehabilitationskliniken Ulm (RKU)
  Zentrum für Seltene Erkrankungen am Universitätsklinikum Ulm
  
• albert.*******@***.de

Claim this profile

• Research area/topic:
  MULTIMONO : A multicentric approach to monocyte alterations in ALS
• Universitäts- und Rehabilitationskliniken Ulm (RKU)
  Zentrum für Seltene Erkrankungen am Universitätsklinikum Ulm
  
• jochen.w********@***_ulm.de

Claim this profile

• Research area/topic:
  Aggregated-TDP43: Detection of disease specific aggregates of TDP-43 in cerebrospinal fluid of ALS patients for disease specific diagnosis
• Universitäts- und Rehabilitationskliniken Ulm (RKU)
  Zentrum für Seltene Erkrankungen am Universitätsklinikum Ulm
  
• marku******@***_ulm.de

Claim this profile

• Research area/topic:
  Behavioral Changes in ALS: What Families and Health Care Professionals need to know
• Neurology Department, Beaumont Hospital
  Trinity College Dublin
  Trinity College Dublin
  
• hard****@***.ie

Claim this profile

• Research area/topic:
  REALS: Repurposed Enoxacin for the treatment of patients with Amyotrophic Lateral Sclerosis
• Arnold R. Meyer Institute of Biological Sciences, Weizmann Institute of Science
  
• eran.ho*******@***zmann.ac.il

Claim this profile

• Research area/topic:
  ALS-degeneration: The molecular basis for neurodegeneration and muscle atrophy in ALS - IL
• Sackler Faculty of Medicine, University of Tel-Aviv
  
• era***@***t.tau.ac.il

Claim this profile

• Research area/topic:
  Amyotrophic lateral sclerosis (SLA) and riboflavin responsive multiple Acyl-CoA dehydrogenase deficiency (RR-MADD)
• Dipartimento di Bioscienze Biotecnologie e Scienze Farmacologiche, Università degli Studi di Bari Aldo Moro
  
• m.ba****@***logia.uniba.it

Claim this profile

• Research area/topic:
  Modulating motor neuron vulnerability using the oculomotor restricted genes IGF-2 and SYT13 for ALS therapy
• Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
  Dipartimento di Neuroscienze e Salute Mentale, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
  
• stefani*******@***mi.it

Claim this profile

• Research area/topic:
  Preclinical studies aimed to develop target genes based therapies for the treatment of amyotrophic lateral sclerosis
• Dipartimento di Neuroscienze, Istituto di Ricerche Farmacologiche "Mario Negri"
  
• caterina*********@***ionegri.it

Claim this profile

• Research area/topic:
  Novel biomarkers of amyotrophic lateral sclerosis: role in pathogenesis and possible therapeutic targets
• Istituto di Ricerche Farmacologiche "Mario Negri"
  
• vbon****@***.telethon.it

Claim this profile

• Research area/topic:
  Role of TDP-43 in ALS pathogenesis: understanding TDP-43 aggregates neurotoxicity and the role of tunneling nanotubes in their spreading
• Azienda Ospedaliera Universitaria "Federico II"
  Département de Biologie cellulaire et infection, Institut Pasteur
  
• chiara.*******@***teur.fr

Claim this profile

• Research area/topic:
  Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers
• Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche
  
• pgua*****@***m.cnr.it

Claim this profile

• Research area/topic:
  Novel therapeutic strategies for Spinal Muscular Atrophy: testing the efficacy of cell-permeable peptides in preclinical models
• Centro di Medicina Molecolare, Fondazione Salvatore Maugeri
  
• daniel*******@***maugeri.it

Claim this profile

• Research area/topic:
  Study of the function of mitochondria in mouse models of familial amyotrophic lateral sclerosis associated with the mutations in the SOD1 gene through genetic manipulation of the P66SHC molecular pathway
• Centro Europeo di Ricerca sul Cervello
  
• ca***@***.uniroma2.it

Claim this profile

• Research area/topic:
  Proposal for an integrated approach to rare diseases: a study between basic laboratory models and clinical epidemiology in amyotrophic lateral sclerosis (ALS)
• Centro Nazionale Malattie Rare, ISS - Istituto Superiore di Sanità
  
• alberto*******@***.it

Claim this profile

• Research area/topic:
  Evaluation of disease onset and disease stage/severity in patients with amyotrophic lateral sclerosis using FDG-PET imaging (INSPIRED) - IT
• Dipartimento di Neuroscienze - S.C. Neurologia 4, Ospedale Molinette
  
• adrian******@***to.it

Claim this profile

• Research area/topic:
  PYRAMID: Phenotype Research for ALS modifyer discovery
• Rudolf Magnus Institute Stratenum
  
• j.h.v******@***utrecht.nl

Claim this profile

• Research area/topic:
  Project SOPHIA: Sampling and biomarker OPtimization and Harmonization In ALS and other motor neuron diseases
• Divisie Hersenen, UMC Utrecht - Universitair Medisch Centrum Utrecht
  UMC Utrecht - Universitair Medisch Centrum Utrecht
  UMC Utrecht - Universitair Medisch Centrum Utrecht
  
• lb***@***utrecht.nl

Claim this profile

• Research area/topic:
  Crosstalk between neurotrophic factor receptors (TrkB) and adenosine A2A receptors: implications for Amyotrophic Lateral Sclerosis (ALS).
• Instituto de Medicina Molecular - Faculdade de Medicina da Universidade de Lisboa, Faculdade de Medicina da Universidade de Lisboa
  
• jari*****@***ul.pt

Claim this profile

• Research area/topic:
  Respiratory Rehabilitation in Amyotrophic Lateral Sclerosis: clinical and biochemical impact.
• Departamento de Neurociências, Hospital de Sta. Maria - Centro Hospitalar de Lisboa Norte, EPE.
  Instituto de Medicina Molecular - Faculdade de Medicina da Universidade de Lisboa, Faculdade de Medicina da Universidade de Lisboa
  Serviço de Neurologia, Hospital de Sta. Maria - Centro Hospitalar de Lisboa Norte, EPE.
  
• mame****@***l.telepac.pt

Claim this profile

• Research area/topic:
  Mechanisms of SOD1 toxic aggregation in neurodegenerative processes
• Instituto de Tecnologia Química e Biológica da Universidade Nova de Lisboa, Instituto de Tecnologia Química e Biológica
  
• go***@***b.unl.pt

Claim this profile

• Research area/topic:
  Identification of diagnostic biomarkers for amyotrophic lateral esclerosis
• Hospital de la Santa Creu i Sant Pau
  

Claim this profile

• Research area/topic:
  Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia - ES
• Hospital General Universitario Gregorio Marañón
  
• jose****@***.es

Claim this profile

• Research area/topic:
  Potential of cannabinoids as neuroprotective agents in neurodegenerative disorders: Huntington disease, amyotrophic lateral sclerosis and spinocerebellar ataxia, types 2 and 3
• Dpto. Bioquímica y Biología Molecular, Universidad Complutense de Madrid. Facultad de Medicina
  
• jj**@***.ucm.es

Claim this profile

• Research area/topic:
  Potential of cannabinoids as neuroprotective agents in neurodegenerative disorders: Huntington disease, amyotrophic lateral sclerosis and spinocerebellar ataxia, types 2 and 3
• Dpto. Bioquímica y Biología Molecular, Universidad Complutense de Madrid. Facultad de Medicina
  
• ja**@***.ucm.es

Claim this profile

• Research area/topic:
  In vitro molecular mechanism of amyotrophic lateral sclerosis
• Stockholm University
  

Claim this profile

• Research area/topic:
  Disease mechanisms in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
• Umeå University
  

Claim this profile

• Research area/topic:
  Studies of misfolded SOD1 in amyotrophic lateral sclerosis (ALS)
• Umeå University
  

Claim this profile

• Research area/topic:
  Molecular portfolio of the extraocular muscles: clues to protection in muscular disease
• University Hospital of Umeå
  

Claim this profile

• Research area/topic:
  Genetic factors causing sporadic and familial amyotrophic lateral sclerosis (ALS/MND) with or without dementia
• University Hospital of Umeå
  

Claim this profile

• Research area/topic:
  NEURINOX: NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies
• Département de Pathologie et Immunologie, Centre Médical Universitaire - CMU
  
• karl_hei*********@***ge.ch

Claim this profile

• Research area/topic:
  Amyotrophic Lateral Sclerosis and the DNA Damage Response
• University of Sussex
  
• K.W.Ca*******@***sex.ac.uk

Claim this profile

• Research area/topic:
  EUNEURONE: European Consortium for Research in Neurodegenerative Diseases
• University of Cambridge, John van Geest Centre for Brain Repair
  
• jf***@***.ac.uk

Claim this profile

• Research area/topic:
  Cellular and molecular insights into neurodegeneration mediated by the C9orf72 gene mutation amyotrophic lateral sclerosis
• University of Edinburgh
  

Claim this profile

• Research area/topic:
  The contribution of cell autonomous and non-cell autonomous effects of mutant TDP-43 to disease onset and progression in a novel transgenic mouse model of ALS
• Medical science division, University of Oxford, John Radcliffe Hospital, University of Oxford
  

Claim this profile

• Research area/topic:
  Identifying effectors of mutant C9Orf72 ALS/FTD to combat neurodegeneration
• Medical science division, University of Oxford, John Radcliffe Hospital, University of Oxford
  Department of Physiology Anatomy & Genetics, Le Gros Clark Building - University of Oxford
  Department of Physiology, Anatomy and Genetics, Le Gros Clark Building - University of Oxford
  
• kevin.******@***g.ox.ac.uk

Claim this profile

• Research area/topic:
  Development of a diagnostic test for familial amyotrophic lateral sclerosis type 6 through mutation screening in FUS gene
• National Hospital for Neurology and Neurosurgery
  The James Black Centre, The Institute of Psychiatry, King's College London School of Medicine
  

Claim this profile

• Research area/topic:
  Modelling peripheral axonal pathology of ALS in vitro - Assembly of optogenetic neuromuscular circuits from pluripotent stem cells
• Division of Genetics and Molecular Medicine, Kings College School of Medicine
  
• ivo.li******@***.ac.uk

Claim this profile

• Research area/topic:
  Study the role of TDP43, a new gene mutation identified recently for amyotrophic lateral sclerosis in motor neurons
• The National Hospital For Neurology and Neurosurgery
  
• e.fi****@***on.ucl.ac.uk

Claim this profile

• Research area/topic:
  Novel and bespoke mouse models for dissecting neurodegenerative disease
• The National Hospital For Neurology and Neurosurgery
  Institution: Information not provided - UK
  UCL Institute of Neurology, University College London,
  
• elizabet********@***.ac.uk

Claim this profile

• Research area/topic:
  Investigating deficits of axonal RNA metabolism and axonal signalling in amyotrophic lateral sclerosis
• UCL Institute of Neurology, University College London,
  Faculty of Medical Sciences Newcastle University
  
• pietro*******@***.net

Claim this profile

• Research area/topic:
  Beyond the neuromuscular junction: dysfunction of spinal synaptic targets of motoneurons in Amyotrophic Lateral Sclerosis
• UCL Institute of Neurology, University College London,
  
• be***@***.ac.uk

Claim this profile

• Research area/topic:
  Investigating deficits of axonal RNA metabolism and axonal signalling in amyotrophic lateral sclerosis
• UCL Institute of Neurology, University College London,
  Faculty of Medical Sciences Newcastle University
  
• pietro*******@***.net

Claim this profile

• Research area/topic:
  Novel and bespoke mouse models for dissecting neurodegenerative disease
• The National Hospital For Neurology and Neurosurgery
  Institution: Information not provided - UK
  UCL Institute of Neurology, University College London,
  
• elizabet********@***.ac.uk

Claim this profile

• Research area/topic:
  Identifying effectors of mutant C9Orf72 ALS/FTD to combat neurodegeneration
• Medical science division, University of Oxford, John Radcliffe Hospital, University of Oxford
  Department of Physiology Anatomy & Genetics, Le Gros Clark Building - University of Oxford
  Department of Physiology, Anatomy and Genetics, Le Gros Clark Building - University of Oxford
  
• kevin.******@***g.ox.ac.uk

Claim this profile

• Research area/topic:
  Developing The Oxford Study for Biomarkers in Motor Neuron Disease (BioMOx): Capturing pre-symptomatic events and advancing clinical translation
• Department of Physiology, Anatomy and Genetics, Le Gros Clark Building - University of Oxford
  
• p*@***n.ox.ac.uk

Claim this profile

• Research area/topic:
  The pathophysiological role of TDP43 in amyotrophic lateral sclerosis due to C9orf72 mutations
• Department of Physiology, Anatomy and Genetics, Le Gros Clark Building - University of Oxford
  

Claim this profile

• Research area/topic:
  Antisense Oligonucleotide Therapy for Neuromuscular Disease
• Department of Physiology, Anatomy and Genetics, Le Gros Clark Building - University of Oxford
  University of Oxford
  
• matthe******@***g.ox.ac.uk

Claim this profile

• Research area/topic:
  The role of Miro and PKC signalling in axonal transport defects in amyotrophic lateral sclerosis.
• Sheffield Institute of Translational Neuroscience, University of Sheffield
  
• rebecc*******@***ffield.ac.uk

Claim this profile

• Research area/topic:
  MITOTARGET: mitochondrial dynamics in neurodegenerative diseases and assessment of the effects of new small molecules (WP1)
• Sheffield Institute of Translational Neuroscience, University of Sheffield
  
• a.j.gr******@***ffield.ac.uk

Claim this profile

• Research area/topic:
  Investigating mechanistic causes of C9ORF72-related amyotrophic lateral sclerosis (ALS).
• Sheffield Institute of Translational Neuroscience, University of Sheffield
  
• bev.c*****@***ffield.ac.uk

Claim this profile

• Research area/topic:
  Investigating the role of exosomal RNA in C9orf72 astrocyte toxicity - moving towards gene therapy approaches
• Sheffield Institute of Translational Neuroscience, University of Sheffield
  

Claim this profile

• Research area/topic:
  MITOTARGET: mitochondrial metabolic function and oxidative stress in neurodegenerative diseases and assessment of the effects of new small molecules (WP3)
• University of Sheffield, E Floor Medical School, The Medical School - University of Sheffield
  
• Pamel******@***ffield.ac.uk

Claim this profile

• Research area/topic:
  Misfolding of Cu/Zn superoxide dismutase by pathological FUS and TDP43: relevance to amyotrophic lateral sclerosis
• Children's Hospital Boston, Boston Children's Hospital
  
• neil.c******@***.ca

Claim this profile